Jiang D - Search Results

1

Development, validation, and clinical application of LC-MS/MS method for simultaneous determination of ibrutinib, zanubrutinib, orelabrutinib, acalabrutinib, and their active metabolites in patients with B-cell lymphoma.

Jiang D, Song Z, Ma Y, Zhang X, Bing H, Xiong X, Hu Y, Dong F, Zhao R. Jiang D, et al. Anal Bioanal Chem. 2024 Dec 19. doi: 10.1007/s00216-024-05701-2. Online ahead of print. Anal Bioanal Chem. 2024. PMID: 39702674

2

Risk of bleeding associated with BTK inhibitor monotherapy: a systematic review and meta-analysis of randomized controlled trials.

Jiang D, Song Z, Hu Y, Dong F, Zhao R. Jiang D, et al. Expert Rev Clin Pharmacol. 2022 Aug;15(8):987-996. doi: 10.1080/17512433.2022.2106968. Epub 2022 Aug 2. Expert Rev Clin Pharmacol. 2022. PMID: 35892246

3

Scope, design, and reporting of prediction models for antineoplastic drugs-related adverse drug events: A systematic review of machine learning and traditional modeling.

Jiang D, Song Z, Hu Y, Li X, Zhao R. Jiang D, et al. J Evid Based Med. 2023 Dec;16(4):420-423. doi: 10.1111/jebm.12558. Epub 2023 Oct 20. J Evid Based Med. 2023. PMID: 37862271 No abstract available.

4

The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis.

Song Z, Hu Y, Liu S, Jiang D, Yi Z, Benjamin MM, Zhao R. Song Z, et al. Among authors: jiang d. Front Pharmacol. 2021 Oct 21;12:757464. doi: 10.3389/fphar.2021.757464. eCollection 2021. Front Pharmacol. 2021. PMID: 34744734 Free PMC article.

5

Long-Term Safety of Rituximab in DLBCL Patients With Hepatitis B-Related Cirrhosis: A Retrospective Case Series.

Song Z, Ma Y, Jiang D, Zhao R, Dong F. Song Z, et al. Among authors: jiang d. Front Med (Lausanne). 2022 May 30;9:890339. doi: 10.3389/fmed.2022.890339. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35712098 Free PMC article.

6

Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey.

Hu Y, Song Z, Jiang D, Zhuo L, Cheng Y, Zhao R. Hu Y, et al. Among authors: jiang d. Front Pharmacol. 2022 Jun 2;13:876503. doi: 10.3389/fphar.2022.876503. eCollection 2022. Front Pharmacol. 2022. PMID: 35721219 Free PMC article.

7

Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety Relationship.

Song Z, Ma L, Bao L, Ma Y, Yang P, Jiang D, Liu A, Zhang L, Li Y, Cheng Y, Dong F, Zhao R, Jing H. Song Z, et al. Among authors: jiang d. Front Pharmacol. 2022 Jun 23;13:931495. doi: 10.3389/fphar.2022.931495. eCollection 2022. Front Pharmacol. 2022. PMID: 35814199 Free PMC article.

8

Toward therapeutic drug monitoring of citalopram in depression? Insights from a systematic review.

Xu N, Song Z, Jiang D, Zhao R. Xu N, et al. Among authors: jiang d. Front Psychiatry. 2023 Apr 27;14:1144573. doi: 10.3389/fpsyt.2023.1144573. eCollection 2023. Front Psychiatry. 2023. PMID: 37181880 Free PMC article.

9

A prediction model for severe hematological toxicity of BTK inhibitors.

Jiang D, Song Z, Liu P, Wang Z, Zhao R. Jiang D, et al. Ann Hematol. 2023 Oct;102(10):2765-2777. doi: 10.1007/s00277-023-05371-7. Epub 2023 Jul 25. Ann Hematol. 2023. PMID: 37491631

10

Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy.

Ma Y, Song Z, Li X, Jiang D, Zhao R, Yi Z. Ma Y, et al. Among authors: jiang d. Clin Pharmacokinet. 2024 Mar;63(3):279-291. doi: 10.1007/s40262-024-01358-3. Epub 2024 Mar 9. Clin Pharmacokinet. 2024. PMID: 38460105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,318 results

Search Page

Filters